Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reparixin after intrahepatic islet transplantation in type 1 diabetes mellitus
2010-019424-31Phase 2Completed
- Sponsor
- Dompé
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of reparixin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Dompé. Primary endpoint: Glycaemic control following intrahepatic infusion of pancreatic islets. Started May 2010; status: completed.
02
Drugs
reparixin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2010-019424-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019424-31.